...of new drugs in dermatology caused in part by large pharmas like Allergan plc and Valeant Pharmaceuticals International Inc....

...a $650 million follow-on. Were it not for 2017’s $6.5 billion in notes deals by Valeant Pharmaceuticals International Inc....

...Next steps could include investigating the mechanism by which brain lymphatic vessels contribute to MS. Valeant Pharmaceuticals International Inc....

...least 8 profitable biotechs and pharmas are slated to report earnings this week. (A) Formerly Valeant Pharmaceuticals International Inc....

...period was aided by $3.8 billion in M&A-related equity raises by Endo International plc and Valeant Pharmaceuticals International Inc....
...Ltd. (HKSE:1833), Shanghai, China Shenogen Pharma Group Ltd. Beijing, China State Drug Administration, Beijing, China Valeant Pharmaceuticals International Inc....

...a complete response letter for Furoscix (scFurosemide) to treat edema in patients with heart failure Valeant Pharmaceuticals International Inc....

...acid (ETC-1002) / ezetimibe ASCVD Top-line Ph III data August EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) / Valeant Pharmaceuticals International Inc....
...NASDAQ:URGN) MitoGel (UGN-101) Low-grade upper tract urothelial carcinoma (UTUC) Top-line Ph III OLYMPUS data 2H18 Valeant Pharmaceuticals International Inc....

...The Ortho Dermatologics unit of Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) said it received a complete response letter from...
...Duobrii is a topical formulation of halobetasol propionate, a corticosteroid, and tazarotene, a retinoid prodrug. Valeant Pharmaceuticals International Inc....